Cargando…
KRAS as a Modulator of the Inflammatory Tumor Microenvironment: Therapeutic Implications
KRAS mutations are one of the most frequent oncogenic mutations of all human cancers, being more prevalent in pancreatic, colorectal, and lung cancers. Intensive efforts have been encouraged in order to understand the effect of KRAS mutations, not only on tumor cells but also on the dynamic network...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833974/ https://www.ncbi.nlm.nih.gov/pubmed/35159208 http://dx.doi.org/10.3390/cells11030398 |